AAAAAA

   
Results: 1-16 |
Results: 16
Intraperitoneal radioimmunochemotherapy of ovarian cancer: A phase I study
Authors: Meredith, RF Alvarez, RD Partridge, EE Khazaeli, MB Lin, CY Macey, DJ Austin, JM Kilgore, LC Grizzle, WE Schlom, J LoBuglio, AF
Citation: Rf. Meredith et al., Intraperitoneal radioimmunochemotherapy of ovarian cancer: A phase I study, CANC BIO R, 16(4), 2001, pp. 305-315
A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti alpha(v)beta(3)) antibody in patients with metastatic cancer
Authors: Posey, JA Khazaeli, MB DelGrosso, A Saleh, MN Lin, CY Huse, W LoBuglio, AF
Citation: Ja. Posey et al., A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti alpha(v)beta(3)) antibody in patients with metastatic cancer, CANC BIO R, 16(2), 2001, pp. 125-132
Expression of human endogenous retrovirus K envelope transcripts in human breast cancer
Authors: Wang-Johanning, F Frost, AR Johanning, GL Khazaeli, MB LoBuglio, AF Shaw, DR Strong, TV
Citation: F. Wang-johanning et al., Expression of human endogenous retrovirus K envelope transcripts in human breast cancer, CLIN CANC R, 7(6), 2001, pp. 1553-1560
Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer
Authors: Robert, F Ezekiel, MP Spencer, SA Meredith, RF Bonner, JA Khazaeli, MB Saleh, MN Carey, D LoBuglio, AF Wheeler, RH Cooper, MR Waksal, HW
Citation: F. Robert et al., Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer, J CL ONCOL, 19(13), 2001, pp. 3234-3243
Quality control of radiolabeled monoclonal antibodies
Authors: Khazaeli, MB
Citation: Mb. Khazaeli, Quality control of radiolabeled monoclonal antibodies, CANC BIO R, 15(6), 2000, pp. 529-530
SEREX analysis for tumor antigen identification in a mouse model of adenocarcinoma
Authors: Hampton, TA Conry, RM Khazaeli, MB Shaw, DR Curiel, DT LoBuglio, AF Strong, TV
Citation: Ta. Hampton et al., SEREX analysis for tumor antigen identification in a mouse model of adenocarcinoma, CANC GENE T, 7(3), 2000, pp. 446-455
Characterization of V-region immunogenicity of CC49 monoclonal antibody inpatients
Authors: Khazaeli, MB Rodenburg, CM Mayo, MS Schlom, J
Citation: Mb. Khazaeli et al., Characterization of V-region immunogenicity of CC49 monoclonal antibody inpatients, TUMOR TARG, 4(4), 1999, pp. 257-265
Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration
Authors: Conry, RM Khazaeli, MB Saleh, MN Allen, KO Barlow, DL Moore, SE Craig, D Arani, RB Schlom, J LoBuglio, AF
Citation: Rm. Conry et al., Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration, CLIN CANC R, 5(9), 1999, pp. 2330-2337
Biodistribution study of Re-188-labeled trisuccin-HuCC49 and trisuccin-HuCC49 Delta CH2 conjugates in athymic nude mice bearing intraperitoneal coloncancer xenografts
Authors: Safavy, A Khazaeli, MB Safavy, K Mayo, MS Buchsbaum, DJ
Citation: A. Safavy et al., Biodistribution study of Re-188-labeled trisuccin-HuCC49 and trisuccin-HuCC49 Delta CH2 conjugates in athymic nude mice bearing intraperitoneal coloncancer xenografts, CLIN CANC R, 5(10), 1999, pp. 2994S-3000S
Targeting strategies for cancer radiotherapy
Authors: Buchsbaum, DJ Rogers, BE Khazaeli, MB Mayo, MS Milenic, DE Kashmiri, SVS Anderson, CJ Chappell, LL Brechbiel, MW Curiel, DT
Citation: Dj. Buchsbaum et al., Targeting strategies for cancer radiotherapy, CLIN CANC R, 5(10), 1999, pp. 3048S-3055S
Comparison of multiple bolus and continuous injections of I-131-labeled CC49 for therapy in a colon cancer xenograft model
Authors: Buchsbaum, DJ Khazaeli, MB Mayo, MS Roberson, PL
Citation: Dj. Buchsbaum et al., Comparison of multiple bolus and continuous injections of I-131-labeled CC49 for therapy in a colon cancer xenograft model, CLIN CANC R, 5(10), 1999, pp. 3153S-3159S
Phase II study of interferon-enhanced I-131-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer
Authors: Meredith, RF Khazaeli, MB Macey, DJ Grizzle, WE Mayo, M Schlom, J Russell, CD LoBuglio, AF
Citation: Rf. Meredith et al., Phase II study of interferon-enhanced I-131-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer, CLIN CANC R, 5(10), 1999, pp. 3254S-3258S
Further studies on the protein conjugation of hydroxamic acid bifunctionalchelating agents: Group-specific conjugation at two different loci
Authors: Safavy, A Khazaeli, MB Kirk, M Coward, L Buchsbaum, DJ
Citation: A. Safavy et al., Further studies on the protein conjugation of hydroxamic acid bifunctionalchelating agents: Group-specific conjugation at two different loci, BIOCONJ CHE, 10(1), 1999, pp. 18-23
Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N ',N '',N '''-tris(acetic acid)cyclododecane (PA-DOTA)
Authors: Chappell, LL Rogers, BE Khazaeli, MB Mayo, MS Buchsbaum, DJ Brechbiel, MW
Citation: Ll. Chappell et al., Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N ',N '',N '''-tris(acetic acid)cyclododecane (PA-DOTA), BIO MED CH, 7(11), 1999, pp. 2313-2320
Idiotypic vaccination with a murine anti-dsDNA antibody: Phase I study in patients with nonactive systemic lupus erythematosus with nephritis
Authors: Spertini, F Leimgruber, A Morel, B Khazaeli, MB Yamamoto, K Dayer, JM Weisbart, RH Lee, ML
Citation: F. Spertini et al., Idiotypic vaccination with a murine anti-dsDNA antibody: Phase I study in patients with nonactive systemic lupus erythematosus with nephritis, J RHEUMATOL, 26(12), 1999, pp. 2602-2608
Paclitaxel derivatives for targeted therapy of cancer: Toward the development of smart taxanes
Authors: Safavy, A Raisch, KP Khazaeli, MB Buchsbaum, DJ Bonner, JA
Citation: A. Safavy et al., Paclitaxel derivatives for targeted therapy of cancer: Toward the development of smart taxanes, J MED CHEM, 42(23), 1999, pp. 4919-4924
Risultati: 1-16 |